|
gptkbp:instanceOf
|
gptkb:drug
Cannabis
|
|
gptkbp:approvedBy
|
gptkb:FDA
|
|
gptkbp:ATCCode
|
A04AD10
|
|
gptkbp:brand
|
gptkb:Marinol
gptkb:Syndros
|
|
gptkbp:CASNumber
|
1972-08-3
|
|
gptkbp:category
|
antiemetic
appetite stimulant
|
|
gptkbp:chemicalFormula
|
C21H30O2
|
|
gptkbp:color
|
oily resin
|
|
gptkbp:controlled_substance
|
yes
|
|
gptkbp:derivedFrom
|
gptkb:tetrahydrocannabinol
|
|
gptkbp:eliminationHalfLife
|
25–36 hours
|
|
gptkbp:first_approved_(US)
|
1985
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
dronabinol
|
|
gptkbp:isomerOf
|
gptkb:Δ⁹-THC
|
|
gptkbp:IUPACName
|
gptkb:(−)-trans-Δ⁹-tetrahydrocannabinol
|
|
gptkbp:legalStatus
|
Schedule III (oral solution: Schedule II)
|
|
gptkbp:mechanismOfAction
|
CB1 receptor agonist
CB2 receptor agonist
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
314.46 g/mol
|
|
gptkbp:pregnancyCategory
|
C
|
|
gptkbp:prescription_required
|
yes
|
|
gptkbp:producedBy
|
synthetic process
|
|
gptkbp:PubChem_CID
|
gptkb:DB00470
16078
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
dizziness
paranoia
drowsiness
euphoria
|
|
gptkbp:solubility
|
insoluble in water
|
|
gptkbp:UNII
|
7J8897W37S
|
|
gptkbp:usedFor
|
treatment of anorexia in AIDS patients
treatment of nausea and vomiting caused by chemotherapy
|
|
gptkbp:bfsParent
|
gptkb:THC
|
|
gptkbp:bfsLayer
|
6
|